Latest Articles

Publication Date
Endometriosis and aspirin: a systematic review.

Endometriosis is delineated as a benign yet steroid-dependent disorder characterized by the ectopic presence of endometrial glandular and stromal cells outside the uterine cavity, affecting estimated 10%-15% of women of …

Published: Aug. 27, 2024, midnight
Having endometriosis can increase ovarian cancer risk 4.2-fold - TechTarget

Having endometriosis can increase ovarian cancer risk 4.2-fold TechTarget

Published: July 19, 2024, 7 a.m.
The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer - Medpage Today

The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer Medpage Today

Published: July 5, 2024, 7 a.m.
The Targeted Pulse: Endometrial Cancer Scores Multiple FDA Approvals, T-DXd Shows Promise in Breast Cancer, and More - Targeted Oncology

The Targeted Pulse: Endometrial Cancer Scores Multiple FDA Approvals, T-DXd Shows Promise in Breast Cancer, and More Targeted Oncology

Published: June 23, 2024, 7 a.m.
Androgen-responsive FOXP4 is a target for endometrial carcinoma | Communications Biology - Nature.com

Androgen-responsive FOXP4 is a target for endometrial carcinoma | Communications Biology Nature.com

Published: June 18, 2024, 7 a.m.
FDA grants breakthrough designation for ovarian cancer liquid biopsy - TechTarget

FDA grants breakthrough designation for ovarian cancer liquid biopsy TechTarget

Published: May 31, 2024, 7 a.m.
Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility.

Endometrioma (OMA), a subtype of endometriosis characterized by the formation of endometriotic cysts in the ovaries, affects 17-44% of individuals diagnosed with endometriosis. Women with OMA often experience compromised fertility, …

Published: April 5, 2024, midnight
Targeting GRP75 with a Chlorpromazine Derivative Inhibits Endometrial Cancer Progression Through GRP75–IP3R-Ca - Wiley Online Library

Targeting GRP75 with a Chlorpromazine Derivative Inhibits Endometrial Cancer Progression Through GRP75–IP3R-Ca Wiley Online Library

Published: Feb. 11, 2024, 8 a.m.
KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer - Targeted Oncology

KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer Targeted Oncology

Published: Jan. 5, 2024, 8 a.m.
Chronic Pelvic Pain, Vulvar Pain Disorders, and Proteomics Profiles: New Discoveries, New Hopes.

Chronic pelvic pain (CPP) is generally defined as non-cyclic pain perceived in the pelvic area that has persisted from three to six months or longer and is unrelated to pregnancy. …

Published: Dec. 19, 2023, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!